Projects per year
Personal profile
Education/Academic qualification
Master
Fingerprint
Dive into the research topics where Yven Van Herrewege is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 10 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Projects
- 2 Active
-
TriDoRe: Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without creating more?
Lynen, L., de Jong, B., Van Deun, A., Decroo, T., Gumusboga, M., Meehan, C., Lempens, P., Rigouts, L., Ratsarahery, L., Van Herrewege, Y., Buyze, J. & Herssens, N.
Flemish Government - Department of Economy, Science & Innovation
1/10/18 → 30/09/24
Project: Research Project
-
SchistoSAM: A proof-of-concept trial to evaluate artesunate-mefloquine as a novel alternative treatment for schistosomiasis in African children
Bottieau, E., Polman, K., Van Herrewege, Y., Rosanas-Urgell, A., Mbow, M., Cisse, B. & Baert, E.
Flemish Government - Department of Economy, Science & Innovation
1/10/18 → 30/09/22
Project: Research Project
Research output
-
Vaccinating children in high-endemic rabies regions: what are we waiting for?
Soentjens, P., Berens-Riha, N., Van Herrewege, Y., Van Damme, P., Bottieau, E. & Ravinetto, R., 10-Feb-2021, In : BMJ Global Health . 6, 2Research output: Contribution to journal › Article
-
Comparative immunogenicity and safety trial of 2 different schedules of single-visit intradermal rabies postexposure vaccination
Soentjens, P., De Koninck, K., Tsoumanis, A., Herssens, N., Van Den Bossche, D., Terryn, S., Van Gucht, S., Van Damme, P., Van Herrewege, Y. & Bottieau, E., 2019, In : Clinical Infectious Diseases. 69, 5, p. 797-804 8 p.Research output: Contribution to journal › A1: Web of Science-article
-
Pre-exposure intradermal rabies vaccination: a non-inferiority trial in healthy adults on shortening the vaccination schedule from 28 to 7 days
Soentjens, P., Andries, P., Aerssens, A., Tsoumanis, A., Ravinetto, R., Heuninckx, W., van Loen, H., Brochier, B., Van Gucht, S., Van Damme, P., Van Herrewege, Y. & Bottieau, E., 2019, In : Clinical Infectious Diseases. 68, 4, p. 607-614 8 p.Research output: Contribution to journal › A1: Web of Science-article
-
Time of administration of rabies immunoglobulins and adequacy of antibody response upon post-exposure prophylaxis: a descriptive retrospective study in Belgium
Soentjens, P., Croughs, M., Burm, C., Declerq, S., Clerinx, J., Maniewski, U., Van Den Broucke, S., Theunissen, C., Huits, R., Brosius, I., Florence, E., Kenyon, C., Van Griensven, J., Van Ierssel, S., Lynen, L., Balliauw, K., Van Gucht, S., Van Esbroeck, M., Vlieghe, E., Bottieau, E. & 1 others, , 4-Sep-2019, In : Acta Clinica Belgica. p. 1-7 7 p.Research output: Contribution to journal › A1: Web of Science-article
-
In vitro synergistic activity against CCR5-tropic HIV-1 with combinations of potential candidate microbicide molecules HHA, KRV2110 and enfuvirtide (T20)
Jenabian, MA., Saïdi, H., Charpentier, C., Van Herrewege, Y., Son, JC., Schols, D., Balzarini, J., Vanham, G. & Bélec, L., 2009, In : Journal of Antimicrobial Chemotherapy. 64, 6, p. 1192-1195 4 p.Research output: Contribution to journal › A1: Web of Science-article